Spire Healthcare Group (LON:SPI) Stock Price Down 16.9% – Here’s Why

Spire Healthcare Group plc (LON:SPI) was down 16.9% during mid-day trading on Wednesday . The stock traded as low as GBX 185 and last traded at GBX 185.80. Approximately 8,659,000 shares changed hands during mid-day trading, an increase of 493% from the average daily volume of 1,461,109 shares. The stock had previously closed at GBX 223.50.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. lowered their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a research report on Tuesday, August 5th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of GBX 294.33.

Spire Healthcare Group Trading Down 16.9%

The stock has a market cap of £747.61 million, a PE ratio of 40.39, a PEG ratio of 1.06 and a beta of 0.96. The company’s fifty day moving average is GBX 234.27 and its 200-day moving average is GBX 222.02. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.